13F-HR filed by TANG CAPITAL MANAGEMENT LLC
TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 20 holding rows worth $552,680,000.
- Accession
- 0001214659-20-009570
- Filer
- CIK 1232621
- Filed
- 2020-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 20 entries on the cover page, a total value of $552,680,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $552,680,000 with VALUE read as thousands by filing date, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerTANG KEVIN C028-14818
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ODONATE THERAPEUTICS INC | 676079106 | COM | 15,238,782 | $204,657,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 2,965,485 | $67,791,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 2,896,904 | $42,932,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 599,091 | $38,947,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 2,628,678 | $38,773,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 9,405,490 | $37,904,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 40,000 | $20,618,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 500,000 | $18,810,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 160,000 | $16,160,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,578,795 | $14,920,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 1,246,121 | $12,573,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 550,000 | $10,087,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 700,000 | $9,114,000 | thousands by filing date | |
| LIFESCI ACQUISITION CORP | 53228P208 | UNIT 03/31/2025 | 500,000 | $6,800,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 468,750 | $4,856,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 62,262 | $2,645,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 191,426 | $1,849,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 178,688 | $1,785,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 112,880 | $751,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L209 | COM | 460,000 | $708,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-20-009570 | this filing | 2020-11-16 | acceptance time not in the bulk data set |